Evidence map›Paper›PMID 38899873›Full record

ArticleThe journal of physical chemistry letters2024

Thioflavin T─a Reporter of Microviscosity in Protein Aggregation Process: The Study Case of α-Synuclein.

Konstantin Rusakov, Aadil El-Turabi, Lasse Reimer, Poul Henning Jensen, Piotr Hanczyc

Abstract read
In one paragraph

Article in The journal of physical chemistry letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Overexpression inFrontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Konstantin RusakovFaculty of Construction and Environmental Engineering, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.ORCID 0000-0002-6683-0547
Aadil El-TurabiUniversity of Oxford, Jenner Institute, Nuffield Department of Medicine, OX3 7DQ Oxford, U.K.
Lasse ReimerDANDRITE, Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Poul Henning JensenDANDRITE, Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Piotr HanczycInstitute of Experimental Physics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093 Warsaw, Poland.ORCID 0000-0002-1460-8477

Funding

Medical Research Council MR/T046287/1
6 · The paper itself

Abstract

Thioflavin T (ThT) informed microviscosity changes can be used to monitor protein aggregation. Steady-state, time-resolved and lasing spectroscopy were used to detect transient states in α-synuclein - a protein associated with Parkinson's disease. The major focus was on the nucleation phase, where conventional ThT fluorescence assay lacks appropriate sensitivity to detect early stage oligomers. Instead, lasing spectroscopy and lasing threshold parameters, in particular, were sensitive to detecting protein oligomers. Through lasing spectroscopy, a change in microviscosity correlating with the stages of protein aggregation was observed at two wavelengths 405 and 440 nm. The two wavelengths are associated with free dye molecules and β-sheet bound ThT molecules. This provides a perspective on elucidating the early formed protein aggregation, a critical aspect in understanding the pathogenesis of neurodegenerative diseases. The insights from the presented study shows the potential of using lasing spectroscopy as a sensitive tool in studying protein aggregation dynamics.

Indexed as

alpha-SynucleinBenzothiazolesProtein AggregatesFluorescent DyesHumansSpectrometry, FluorescenceViscosityalpha-SynucleinBenzothiazolesFluorescent DyesProtein Aggregatesthioflavin T

Identifiers

PMID38899873
PMCPMC11215780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.